Evidence map›Paper›PMID 38477582›Full record

ArticleJournal of medicinal chemistry2024

Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant Protein.

John M Ketcham, Stephen J Harwood, Ruth Aranda, Athenea N Aloiau, Briana M Bobek, David M Briere, Aaron C Burns, Kersti Caddell Haatveit, Andrew Calinisan, Jeffery Clarine and 20 more

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Free energy landscape of the PI3Kα C-terminal activation.Computational and structural biotechnology journal · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

John M KetchamMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.ORCID 0000-0001-5011-9593
Stephen J HarwoodMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Ruth ArandaMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Athenea N AloiauMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Briana M BobekMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
David M BriereMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Aaron C BurnsMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Kersti Caddell HaatveitMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Andrew CalinisanMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Jeffery ClarineMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Adam ElliottMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Lars D EngstromMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Robin J GunnMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Anthony IvetacMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Benjamin JonesMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Jon KuehlerMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
J David LawsonMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.ORCID 0000-0002-5232-4539
Natalie NguyenMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Cody ParkerMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Kelly E PearsonMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Lisa RahbaekMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Barbara SaechaoMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Xiaolun WangMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Anna WatersMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Laura WatersMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Ashlee H WatkinsMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Peter OlsonMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Christopher R SmithMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
James G ChristensenMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.
Matthew A MarxMirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States.ORCID 0000-0003-2351-4787

Funding

User Training and OutreachP30GM124165 · NIGMS · CORNELL UNIVERSITY · PI Nozomi Ando, J Christopher Fromme · 2018 to 2026
$34.2M
Pixel Array Detector for Macromolecular CrystallographyS10OD021527 · OD · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2016 to 2016
$2.0M
CIHRNIGMS NIH HHS P30 GM124165NIH HHS S10 OD021527
6 · The paper itself

Abstract

The H1047R mutation of

Indexed as

Antineoplastic AgentsNeoplasmsAnimalsClass I Phosphatidylinositol 3-KinasesMiceMutationPhosphoinositide-3 Kinase InhibitorsAntineoplastic AgentsClass I Phosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase Inhibitors

Identifiers

PMID38477582
PMCPMC10983000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.